Literature DB >> 34372896

Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis.

Shizhao Cheng1, Yiyao Jiang2, Xin Li1, Xike Lu1, Xun Zhang1, Daqiang Sun3.   

Abstract

OBJECTIVE: The prevalence of patients with concomitant heart and lung lesions requiring surgical intervention is increasing. Simultaneous cardiac surgery and pulmonary resection avoids the need for a second operation. However, there are concerns regarding the potentially increased mortality and complication rates of simultaneous surgery and the adequacy of lung exposure during heart surgery. Therefore, we performed a meta-analysis to evaluate the perioperative mortality and complication rates of combined heart surgery and lung tumor resection.
METHODS: A comprehensive literature search was performed in July 2020. The PubMed, Embase, and Web of Science databases were searched to identify studies that reported the perioperative outcomes of combined heart surgery and lung tumor resection. Two reviewers independently screened the studies, extracted data, and assessed the risk of bias of included studies. Pooled proportions and 95% confidence intervals (95% CI) were calculated by R version 3.6.1 using the meta package.
RESULTS: A total of 536 patients from 29 studies were included. Overall, the pooled proportion of operative mortality was 0.01 (95% CI: 0.00, 0.03) and the pooled proportion of postoperative complications was 0.40 (95% CI: 0.24, 0.57) for patients who underwent combined cardiothoracic surgery. Subgroup analysis by lung pathology revealed that, for patients with lung cancer, the pooled proportion of anatomical lung resection was 0.99 (95% CI: 0.95, 1.00) and the pooled proportion of systematic lymph node dissection or sampling was 1.00 (95% CI: 1.00, 1.00). Subgroup analysis by heart surgery procedure found that the pooled proportion of postoperative complications of patients who underwent coronary artery bypass grafting (CABG) patients using the off-pump method was 0.17 (95% CI: 0.01, 0.43), while the pooled proportion of complications after CABG using the on-pump method was 0.61 (95% CI: 0.38, 0.82).
CONCLUSION: Combined heart surgery and lung tumor resection had a low mortality rate and an acceptable complication rate. Subgroup analyses revealed that most patients with lung cancer underwent uncompromised anatomical resection and mediastinal lymph node sampling or dissection during combined cardiothoracic surgery, and showed off-pump CABG may reduce the complication rate compared with on-pump CABG. Further researches are still needed to verify these findings.
© 2021. The Author(s).

Entities:  

Keywords:  Combined cardiothoracic surgery; Heart surgery; Lung surgery; Meta-analysis; Perioperative outcomes

Year:  2021        PMID: 34372896     DOI: 10.1186/s13019-021-01607-7

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  41 in total

1.  Simultaneous cardiac and lung surgery for incidental solitary pulmonary nodule: learning from the past.

Authors:  R Zhang; B Wiegmann; S Fischer; N J Dickgreber; C Hagl; M Krüger; A Haverich; P Zardo
Journal:  Thorac Cardiovasc Surg       Date:  2011-07-07       Impact factor: 1.827

2.  Synchroneously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach.

Authors:  A J Voets; K S Joesoef; M E van Teeffelen
Journal:  Eur J Cardiothorac Surg       Date:  1997-11       Impact factor: 4.191

3.  Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency.

Authors:  Xuchen Ma; Fangjiong Huang; Zhitai Zhang; Feiqiang Song; Songlei Ou
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  Lung resection for cancer in patients with coronary arterial disease: analysis of short-term results.

Authors:  Paola Ciriaco; Angelo Carretta; Giliola Calori; Patrizio Mazzone; Piero Zannini
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

5.  Concomitant cardiac surgery and pulmonary resection.

Authors:  K Cathenis; R Hamerlijnck; F Vermassen; G Van Nooten; F Muysoms
Journal:  Acta Chir Belg       Date:  2009 May-Jun       Impact factor: 1.090

6.  Combined operation for lung cancer and cardiac disease.

Authors:  D L Miller; T A Orszulak; P C Pairolero; V F Trastek; H V Schaff
Journal:  Ann Thorac Surg       Date:  1994-10       Impact factor: 4.330

7.  Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease.

Authors:  Ali Yeginsu; Mustafa Vayvada; Burcin C Karademir; Atakan Erkılınç; Ahmet Erdal Tasci; Fuat Buyukbayrak; Emre Gurcu; Cemal Asım Kutlu
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

8.  Effect of simultaneous surgical treatment of severe coronary artery disease and lung cancer.

Authors:  Zhi Li; Ban Liu; Wen Ge; Wei Zhang; Chang Gu; Jingjing Liu; Xianting Ke; Yangyang Zhang
Journal:  J Int Med Res       Date:  2018-10-14       Impact factor: 1.671

Review 9.  Global Epidemiology of Lung Cancer.

Authors:  Julie A Barta; Charles A Powell; Juan P Wisnivesky
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.